We are live on ! Find out more
BCA

Benchmark Capital Advisors Portfolio holdings

AUM $101M
1-Year Est. Return 0.8%
This Fund
S&P 500
This Quarter Est. Return
-11.15%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
AUM
$101M
AUM Growth
-$32.5M
Cap. Flow
-$16.1M
Cap. Flow %
-16.04%
Top 10 Hldgs %
35.51%
Holding
136
New
2
Increased
26
Reduced
56
Closed
21

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.43M
2
WBA
Walgreens Boots Alliance
WBA
+$2.06M
3
MDLZ icon
Mondelez International
MDLZ
+$1.66M
4
NFLX icon
Netflix
NFLX
+$1.09M
5
AVT icon
Avnet
AVT
+$1.03M

Sector Composition

Rank Sector Weight
1 Real Estate 15.61%
2 Technology 13.31%
3 Healthcare 12.16%
4 Financials 11.92%
5 Communication Services 6.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEVA icon
51
Teva Pharmaceuticals
TEVA
$36.5B
$533K 0.53%
34,544
-7,000
-17% -$144K
RGLD icon
52
Royal Gold
RGLD
$16B
$531K 0.53%
6,200
RWT
53
Redwood Trust
RWT
$632M
$527K 0.52%
34,966
CEMI
54
DELISTED
Chembio diagnostics, Inc.
CEMI
$515K 0.51%
90,929
-9,606
-10% -$70.8K
BRK.B icon
55
Berkshire Hathaway Class B
BRK.B
$1.06T
$470K 0.47%
2,300
MS.PRA icon
56
Morgan Stanley Series A Preferred Stock
MS.PRA
$761M
$457K 0.45%
24,105
+400
+2% +$8.21K
MET.PRA icon
57
MetLife Inc Floating Rate Series A
MET.PRA
$509M
$444K 0.44%
21,200
RDI icon
58
Reading International Class A
RDI
$30.2M
$416K 0.41%
28,600
-2,500
-8% -$37.5K
DOC icon
59
Healthpeak Properties
DOC
$15.4B
$408K 0.41%
14,600
-2,300
-14% -$63.7K
SRPT icon
60
Sarepta Therapeutics
SRPT
$1.81B
$398K 0.4%
3,650
-350
-9% -$43.8K
SNY icon
61
Sanofi
SNY
$105B
$386K 0.38%
8,900
-400
-4% -$17.6K
VTNR
62
DELISTED
Vertex Energy, Inc
VTNR
$368K 0.37%
360,969
-4,800
-1% -$7.2K
VZ icon
63
Verizon
VZ
$181B
$367K 0.37%
6,536
+12
+0.2% +$681
GLD icon
64
SPDR Gold Trust
GLD
$129B
$364K 0.36%
3,000
GE icon
65
GE Aerospace
GE
$353B
$359K 0.36%
9,896
-6,573
-40% -$297K
VTI icon
66
Vanguard Total Stock Market ETF
VTI
$659B
$357K 0.36%
2,795
+90
+3% +$12.4K
CTSH icon
67
Cognizant
CTSH
$21.1B
$333K 0.33%
5,250
QQQ icon
68
Invesco QQQ Trust
QQQ
$465B
$332K 0.33%
2,155
+60
+3% +$10K
PCI
69
DELISTED
PIMCO Dynamic Credit and Mortgage Income Fund
PCI
$324K 0.32%
15,400
MFA
70
MFA Financial
MFA
$942M
$312K 0.31%
11,675
-1,250
-10% -$35.1K
MUC icon
71
BlackRock MuniHoldings California Quality Fund
MUC
$1.02B
$308K 0.31%
25,000
PTY icon
72
PIMCO Corporate & Income Opportunity Fund
PTY
$2.51B
$301K 0.3%
19,600
VNQ icon
73
Vanguard Real Estate ETF
VNQ
$39.4B
$297K 0.3%
3,980
-115
-3% -$9.06K
VXX
74
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$293K 0.29%
+6,250
New +$231K
GM.WS.B
75
CALL
DELISTED
General Motors Company
GM.WS.B
$292K 0.29%
18,346

Similar funds

Benchmark Capital Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Benchmark Capital Advisors held 136 positions worth $101M, down 24% from $133M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Benchmark Capital Advisors withdrew a net $16.1M in Q4 2018, closing 21 positions and reducing 56 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $2.06M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 16% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Benchmark Capital Advisors opened a new position in DuPont de Nemours worth $1.39M.

  • Benchmark Capital Advisors's largest Q4 2018 buy was DuPont de Nemours: 10,227 shares worth $1.39M.
  • Benchmark Capital Advisors added most to Meta Platforms (Facebook) in Q4 2018, an estimated $456K increase.
  • Benchmark Capital Advisors's biggest Q4 2018 reduction was Apple, cutting an estimated $4.43M.
  • Benchmark Capital Advisors fully exited Walgreens Boots Alliance in Q4 2018, selling an estimated $2.06M.
  • Benchmark Capital Advisors's ten largest holdings make up 36% of its $101M portfolio in Q4 2018.
  • Benchmark Capital Advisors opened 2 new positions and closed 21 in Q4 2018.
  • Benchmark Capital Advisors's portfolio value fell 24% quarter-over-quarter to $101M.

Based on Benchmark Capital Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.